IFV News: GeoVax Labs - Coming Closer to an HIV Stopping Vaccine

Feature Story - IFV speaks with Dr. Robert McNally - President & CEO of GeoVax Labs - about how this small Georgia based biotech company is today the leading vaccine candidate for the prevention of HIV. Dr. McNally tells us about the work of Harriet L. Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs and her team. They've recently announced the results of a study suggesting that scientists may be one step closer to a vaccine that protects against multiple exposures to HIV infections.

GeoVax speaks with us from Rodman and Renshaw in New York City, this investment bank provides a number of services to public and private companies across multiple sectors; it also services institutional investors.

Released 5/12/12

Видео IFV News: GeoVax Labs - Coming Closer to an HIV Stopping Vaccine канала The M.INK Media Company